Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News IM Cannabis Corp C.IMCC

Alternate Symbol(s):  IMCC

Healthcare
IM Cannabis Corp. is a Canada-based medical cannabis company. The Company operates in Israel through its commercial relationship with Focus Medical Herbs Ltd. (Focus Medical), which has a cultivation license to breed, grow and supply medical cannabis products in Israel. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centres and logistical hubs in... see more

Recent & Breaking News (CSE:IMCC)

IM Cannabis Closes First Tranche of Non-Brokered Listed Issuer Financing Exemption Offering and its Concurrent Offering

Canada NewsWire January 16, 2023

IM Cannabis (CSE:IMCC) announces two non-brokered private placements

John Ballem  January 13, 2023

IM Cannabis announces Non-Brokered Private Placement Offerings of up to an Aggregate of US$5,500,000

Canada NewsWire January 13, 2023

IM Cannabis Common Shares Commence Trading on Consolidated Basis After 1 for 10 Reverse Stock Split

PR Newswire November 17, 2022

CSE Bulletin: Consolidation - IM Cannabis Corp. (IMCC)

Newsfile November 15, 2022

IM Cannabis Reports Third Quarter 2022 Financial Results; Revenues Increased 78% YoY and 12% Sequentially

PR Newswire November 14, 2022

IM Cannabis to Focus on Israel, German and European Growth; Commences Exiting the Canadian Cannabis Market

PR Newswire November 7, 2022

IM Cannabis to Report Third Quarter 2022 Financial Results on Monday, November 14 at 9:00am ET

PR Newswire November 1, 2022

IM Cannabis's Legacy Strain 'Roma' Voted Israel's Favourite Strain of the Month for August 2022

PR Newswire October 26, 2022

Avant Brands and IM Cannabis Announce the Launch of BLK MKT in Israel

PR Newswire October 12, 2022

IM Cannabis Closes Second Tranche of Non-Brokered Private Placement of Common Shares

PR Newswire October 6, 2022

IM Cannabis Closes Second Tranche of Non-Brokered Private Placement of Common Shares

Canada NewsWire October 5, 2022

SNDL and IM Cannabis Complete SNDL's First International Export of Premium Dried Flower from Canada to Israel

PR Newswire September 15, 2022

IM Cannabis Welcomes Two New Members to its Board of Directors

PR Newswire September 13, 2022

RAFAEL GABAY ACQUIRES COMMON SHARES OF IM CANNABIS CORP.

PR Newswire September 8, 2022

IM Cannabis Closes First Tranche of Non-Brokered Private Placement of Common Shares

Canada NewsWire August 24, 2022

IM Cannabis (CSE:IMCC) announces US$5M private placement

John Ballem  August 19, 2022

IM Cannabis Announces USD$5,000,000 Private Placement Led by Management

Canada NewsWire August 19, 2022

IM Cannabis Reports Record Second Quarter 2022 Financial Results; Revenues Increase 114% YoY to $23.8 Million

PR Newswire August 15, 2022

Xinteza Unveils Disruptive Non-Cannabaceae Source for Cannabinoid Biosynthesis in Breakthrough Research Led by Prof. Asaph Aharoni at the Weizmann Institute of Science

PR Newswire August 11, 2022